By Jeffrey Schulze, CFA, Investment Strategist, ClearBridge Investments In this episode, we speak with Jeff Schulze, head of economic and market research at ClearBridge...
Investment Summary Following a series of investment updates since my April publication on Avanos Medical, Inc. (NYSE:AVNS), there is still the potential to unlock...
Introduction Invitae (NYSE:NVTA) is a leading provider of genetic testing services, digital health solutions, and health data services. Their genetic tests cover various clinical...